Saud Alsifri

Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global <scp>HAT</scp> study

Kamlesh Khunti, Saud Alsifri, Ronnie Aronson et al. · Diabetes Obesity and Metabolism · 2016 · 274 citations · Full text

Medicine, Endocrinology, Internal Medicine +14

Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes

Kamlesh Khunti, Saud Alsifri, Ronnie Aronson et al. · Diabetes Research and Clinical Practice · 2017 · 73 citations · Full text

Medicine, Endocrinology, Health Sciences +15

Sulfonylureas in the Current Practice of Type 2 Diabetes Management: Are They All the Same? Consensus from the Gulf Cooperation Council (GCC) Countries Advisory Board on Sulfonylureas

Yousef Al‐Saleh, Shaun Sabico, Ahmed Al-Furqani et al. · Diabetes Therapy · 2021 · 18 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Evaluating the Clinical Effectiveness and Safety of Semaglutide in Individuals with Uncontrolled Type 2 Diabetes. Real-World Evidence from Saudi Arabia: The Observational, Multicenter, 15-Month EVOLUTION Study

Abdulrahman Alsheikh, Ali Alshehri, Saad Alzahrani et al. · Diabetes Therapy · 2023 · 16 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

COVID-19 and Saudi Arabia public financing of prescription drugs: An opportunity for reform

Yazed AlRuthia, Sulaiman A. Alrashed, Bander Balkhi et al. · Health Policy and Technology · 2020 · 11 citations

Public Affairs, Health Policy, Pharmaceutical Policy +14